|
HS Code |
188995 |
| Chemical Formula | C3HClN2O2S |
| Molecular Weight | 164.57 |
| Appearance | Yellow crystals or powder |
| Melting Point | 118 - 122 °C |
| Solubility In Water | Insoluble |
| Solubility In Organic Solvents | Soluble in some organic solvents like ethanol, chloroform |
| Stability | Stable under normal conditions, but may react with strong oxidizing agents |
| Hazard | Harmful if swallowed, inhaled or in contact with skin; irritant to eyes |
As an accredited 2-Chloro-5-Nitrothiazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 250 - gram bottle of 2 - Chloro - 5 - Nitrothiazole, well - sealed for chemical storage. |
| Shipping | 2 - Chloro - 5 - Nitrothiazole is shipped in sealed, corrosion - resistant containers. Compliance with hazardous chemical shipping regulations is ensured, with proper labeling indicating its nature for safe transportation. |
| Storage | 2 - Chloro - 5 - nitrothiazole should be stored in a cool, dry, well - ventilated area. Keep it away from heat sources, flames, and incompatible substances like strong oxidizers. Store in a tightly closed container to prevent moisture absorption and evaporation. Label the storage container clearly to avoid misidentification. |
|
In the manufacture of nitazoxanide and its pharmacopoeial analogues, 2-chloro-5-nitrothiazole serves as the primary heterocyclic building block that defines the activity-conferring 5-nitrothiazol-2-yl pharmacophore. The established industrial route proceeds through sealed-vessel aminolysis in 25% aqueous ammonia at 105–110°C (3.5–4.0 bar) within 316L stainless steel autoclaves, yielding 2-amino-5-nitrothiazole after neutralisation and centrifuge isolation; this intermediate must exhibit an area-normalised purity exceeding 99.7% by HPLC (USP <621>) before acylation with 2-acetoxybenzoyl chloride. Batch records from multi-ton campaigns indicate that exceeding a peak jacket temperature of 112°C during the exothermic aminolysis stage increases the dimeric impurity bis(5-nitrothiazol-2-yl)amine above the 0.10% threshold mandated under the ICH Q3A reporting limit for nitazoxanide drug substance at a daily dose of 1 g. The acylation step is conducted in anhydrous dichloromethane or tetrahydrofuran with triethylamine as a proton scavenger, maintaining an internal temperature below 5°C to suppress ring-dehalogenation side reactions that generate the des-chloro impurity tracked in the USP Nitazoxanide monograph (related compound C, USP reference standard 1463509). Residual solvent profiles must comply with ICH Q3C (R8) limits: dichloromethane not exceeding 600 ppm, tetrahydrofuran capped at 720 ppm, and triethylamine controlled below 320 ppm via GC-headspace analytics calibrated against Class 2 residual solvent standards. Finished nitazoxanide API is micronised to a particle size distribution of D₉₀ ≤ 15 µm (Malvern Mastersizer, wet dispersion) for oral suspension formulations, and final product tablets are tested per USP <2040> for dissolution in pH 6.8 phosphate buffer with a Q value of 80% at 45 minutes. The terminal dosage forms encompass immediate-release 500 mg film-coated tablets, 100 mg/5 mL powder-for-suspension paediatric formulations, and veterinary boluses for ruminants, all of which require absence of mutagenic nitrothiazole-related impurities validated by Ames test (OECD 471) at a limit of detection of 10 µg/plate. Halogen-Retentive Suzuki-Miyaura Coupling Sequences for Thiazole-Functionalised Acaricide Lead StructuresIn the synthesis of contact acaricides and piercing-sucking pest insecticides, the C–Cl bond of 2-chloro-5-nitrothiazole is exploited as a cross-coupling handle in palladium-catalysed reactions to construct biaryl or styrenyl architectures while keeping the electron-withdrawing nitro group intact for target-site binding to mitochondrial complex II or nicotinic acetylcholine receptors. A production-scale coupling protocol documented in a 2,000 L glass-lined Hastelloy reactor uses 1.8 mol% Pd(PPh₃)₄ catalyst with 4-substituted phenylboronic acid (1.15 equivalents) in a degassed mixture of toluene:ethanol:water (5:2:1 v/v/v) and a potassium carbonate base loading of 2.5 equivalents at 78–82°C for 18–22 hours. The batch cost structure is dominated by the palladium retention step: filtration through a 0.5 µm sintered-metal candle filter at the end of the reaction reduces catalyst entrainment into the organic phase, and ICP-MS analysis of the crude product must show residual palladium below 20 ppm to meet the procurement specification of generic agrochemical formulators aligned with FAO Specification 548/TC (feb. 2020) for technical-grade active ingredients. Process deviations where the water content exceeds 12% v/v in the initial charge have been directly correlated with a drop in the isolated yield from a baseline of 78% to below 55% due to premature catalyst decomposition through phosphine ligand hydrolysis, a failure mode confirmed by ³¹P NMR monitoring of the spent aqueous layer. Post-coupling reduction of the 5-nitro group using Raney Ni 2800 (slurry in methanol, 4 bar H₂, 50°C) in a loop-reactor configuration produces the corresponding aniline derivative, which is directly employed in the subsequent amidotriazole ring closure to form the pesticidal core. Formulation of the resulting technical-grade acaricide into a 240 g/L suspension concentrate requires wet-milling on a WAB Dyno®-Mill KD 60 with 0.3–0.5 mm yttria-stabilised zirconia beads until the particle size attains a D₉₀ ≤ 3 µm, a critical quality attribute for suspensibility per CIPAC MT 184. The final formulated product is applied in pome fruit and citrus orchards at a spray concentration corresponding to 0.015–0.025% active ingredient, and compliance with the EU residue definition set under Regulation (EC) No 396/2005 requires a Maximal Residue Level validation for the sum of the parent acaricide and its 5-amino-thiazole metabolite. Reprocessing of 2-chloro-5-nitrothiazole into heterocyclic disperse azo colorants for polyester and polyamide fibres relies on the sequential reduction-diazotization-coupling pathway that converts the 5-nitro group into a diazonium electrophile while preserving the 2-chloro substituent for its bathochromic and electron-sink effect in the final dye molecule. In a dedicated dye intermediate plant with segregated equipment trains to avoid cross-contamination of pharma-destined batches, the reduction step uses iron powder (100–200 mesh) in dilute hydrochloric acid at pH 1.5–2.0 at 85–90°C inside a rubber-lined 5,000 L reduction vessel; the resulting 2-chloro-5-aminothiazole is isolated as its hydrochloride salt and is used without drying in the downstream diazotization at 0–5°C with stoichiometric sodium nitrite. The coupling component is usually an N,N-dialkylaniline derivative such as N-ethyl-N-cyanoethylaniline, and the ratio of coupling component to diazonium salt is maintained at 1.02:1.00 to avoid the formation of bis-azo side products that would fail the AATCC Test Method 16.3 lightfastness requirement of Grade 4 or higher on 100% polyester twill. The dispersed dye filter cake is standardised to 40% active content with sodium lignosulfonate (60%) and is dried in a Niro spray dryer at an inlet temperature of 180°C; the resulting granular formulation is dosed at 0.5–3.0% on weight of fabric in high-temperature exhaust dyeing machines at 130°C. All colourants placed on the EU textile market require a ZDHC MRSL Level 3 compliance certificate with verification of absence of restricted arylamines as per EN 14362-1:2017, and the 2-chloro-5-nitrothiazole-derived azo dyes are routinely screened for 4-chloroaniline release potential by reductive cleavage test. When Electron-Transporting Thiazole Monomers Require a Defined C–Cl Co-Polymerization Handle in Non-Fullerene Acceptor BlendsFor the synthesis of all-polymer and small-molecule acceptors in organic photovoltaics, 2-chloro-5-nitrothiazole functions as a symmetrical-electron-deficient precursor that can be functionalised into a distannyl-thiazole monomer suitable for Stille polycondensation with brominated diketopyrrolopyrrole or isoindigo co-monomers. In a controlled glovebox environment (O₂ < 1 ppm, H₂O < 1 ppm), 2-chloro-5-nitrothiazole is first converted to the 2-tri-n-butylstannyl-5-nitrothiazole derivative by lithiation with LDA at −78°C followed by quenching with tributyltin chloride; this stannylated intermediate must be titrated to a concentration of 0.50 M in anhydrous THF before being fed into the polycondensation reactor loaded with a Pd₂(dba)₃/P(o-tol)₃ catalyst system at a monomer:catalyst ratio of 100:1. Molar mass control is achieved by strict monofunctional impurity profiling: the Stille monomer must contain less than 0.3 mol% of protodestannylated species determined by ¹H NMR end-group analysis, otherwise the resulting polymer batch will exhibit a number-average molecular weight (Mₙ) falling below the 35 kDa cutoff required to form adequate domain sizes in the active layer blend. The polymer work-up involves Soxhlet extraction with methanol (removing oligomers below 5 kDa), acetone (removing residual catalyst), and finally dichlorobenzene to recover the photovoltaic-grade fraction. Device fabrication in a pre-production slot-die coater applies a blend of the thiazole-containing acceptor polymer with the donor polymer PM6 at a weight ratio of 1:1.2, dissolved in chloroform:o-xylene (85:15) with 0.5 vol% 1,8-diiodooctane as a processing additive; the wet film thickness is set to 12 µm to yield a dry active-layer thickness of 110–130 nm after annealing at 100°C for 10 minutes on a hotplate under nitrogen. Photovoltaic performance is characterised according to IEC 60904-1:2020 under a Class AAA AM 1.5G solar simulator at 100 mW/cm², and the power conversion efficiency of the thiazole-containing devices is benchmarked against a PCE₁₀ LBG reference with the requirement that the maximum power point tracking stability over 100 hours remains within 90% of the initial value. The terminal product targeted by downstream module manufacturers is a flexible BIPV panel with an aperture area of 0.6 m², necessitating a module-level accelerated aging test per IEC 61215-2:2021 clause MQT 13 (damp heat, 85°C / 85% RH, 1000 hours). In combinatorial synthesis libraries aimed at hit-to-lead progression against kinetoplastid protozoa, 2-chloro-5-nitrothiazole is exploited as a bifunctional scaffold undergoing sequential nucleophilic aromatic substitution under increasingly aggressive conditions to generate a matrix of 2-substituted-5-nitrothiazole analogues. When microwave-assisted parallel synthesis is performed in 10 mL borosilicate vials in a Biotage Initiator+ cavity, the optimal conditions for displacing the 2-chloro leaving group with aliphatic cyclic amines (pyrrolidine, piperidine, morpholine) are found to be 1.2 equivalents of amine in DMF at 120°C for 30 minutes, affording products in 75–92% isolated yield after aqueous workup and flash chromatography on a 40 g silica cartridge with an ethyl acetate:heptane gradient. Competing reduction of the nitro group sets in when secondary amines with strong hydride-donor character (e.g., pyrrolidine) are used in excess beyond 1.5 equivalents at temperatures exceeding 130°C, a side reaction identified by the appearance of an LC-MS signal at m/z M+2 corresponding to the 2-amino-5-nitrothiazole derivative, thus limiting the scope of direct amination in discovery workflows that demand single-component reaction profiles. These nitrothiazole-containing building blocks are subsequently incorporated into high-throughput screening plates, and all dispensing protocols must conform to ANS Z10 occupational hygiene requirements for potentially mutagenic nitroaromatics: solid handling restricted to ISO 5 laminar-flow booths with a face velocity of 0.45 m/s and a receptor-based exposure limit of 1 µg/m³ as an 8-hour TWA derived from the EMA Guideline on setting health-based exposure limits (EMA/CHMP/SWP/463259/2020) for genotoxic impurities in medicinal products. The final research output consists of a library plate containing 48–96 discrete analogues supplied to a screening biology team, and the identity and purity of each member are verified by orthogonal UPLC-UV-ELSD methods with a purity acceptance criterion of ≥ 95% at 254 nm.
|
Competitive 2-Chloro-5-Nitrothiazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
| Parameter | Method / Standard | Limit |
|---|---|---|
| Assay (HPLC) | In‑house SOP aligned to USP <621> | ≥ 98.5 % |
| Melting range | ASTM E794‑06 (DSC, 5 K/min) | 52–55 °C |
| Water content | Karl Fischer coulometry (ASTM D6304) | ≤ 0.5 % |
| Residue on ignition | USP <281>, 600 °C | ≤ 0.1 % |
| Heavy metals | ICP‑MS (ICH Q3D, oral PDE) | Class 1 metals ≤ 2 ppm |
| Chloride (as Cl⁻) | AgNO₃ titration | ≤ 0.2 % |
| Appearance of 10 % solution in acetone | Visual, against white background | Clear, pale yellow |
| Parameter | 2‑Chloro‑5‑nitrothiazole | 2‑Bromo‑5‑nitrothiazole |
|---|---|---|
| Molecular weight | 178.57 g·mol⁻¹ | 223.03 g·mol⁻¹ |
| Melting range (DSC) | 52‑54 °C | 63‑65 °C |
| SNAr t₁/₂ (benzylamine, DMF, 80 °C) | 48–55 min | 8–12 min |
| Adiabatic ΔTad (2 mol·L⁻¹, DMF) | 28 °C | 58 °C |
| Ames outcome (OECD 471) | Negative (≤1 250 µg/plate) | Positive (TA 98, +S9) |